{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-009785","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.496308+00:00","generated_at":"2026-05-25T13:31:19.428691+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ChromaDex reports record Q4 net sales $29.1M (+37% YoY); first full-year net income $8.6M","bullets":["Full-year net sales $99.6M (+19% YoY); Tru Niagen sales $76.8M (+10%), Niagen ingredients $19.2M (+82%).","Q4 net income $7.2M vs $0.1M a year ago; full-year net income $8.6M vs net loss $4.9M in 2023.","Adjusted EBITDA $8.5M in 2024; operating cash flow $12.1M; cash $44.7M with no debt.","G&A expense dropped $6.6M for the year due to $3.5M royalty reversal and $1.3M legal settlement recovery.","FDA granted Orphan Drug and Rare Pediatric Disease Designations for NR; Niagen Plus now at 475+ clinics."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-009785","json":"https://secwatch.observer/filing/0001628280-25-009785.json","markdown":"https://secwatch.observer/filing/0001628280-25-009785.md","text":"https://secwatch.observer/filing/0001628280-25-009785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025009785/0001628280-25-009785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025009785/cdxc-20250304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T13:31:19.428691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}